Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Presta

Showing results (151-160 of 184) with videos related to

Pageof 19
Sort By:
The Journal of Pathology|February 21, 2013
Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancerRoberto Ronca, Patrizia Alessi, Daniela Coltrini, et al.
The Journal of Biological Chemistry|October 3, 2003
Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cellsSimona Taverna, Giulio Ghersi, Angela Ginestra, et al.
European Journal of Medicinal Chemistry|May 18, 2021
Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myelomaRiccardo Castelli, Sara Taranto, Lucia Furiassi, et al.
Angiogenesis|January 1, 1997
Endothelial cells overexpressing basic fibroblast growth factor (FGF-2) induce vascular tumors in immunodeficient miceFrancesco Sola, Anna Gualandris, Mirella Belleri, et al.
Journal of Medicinal Chemistry|February 6, 2004
Undersulfated and glycol-split heparins endowed with antiangiogenic activityBenito Casu, Marco Guerrini, Sara Guglieri, et al.
Blood|November 2, 2006
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factorHelena Stabile, Stefania Mitola, Emanuela Moroni, et al.
Immunity|May 17, 2005
Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptorsPascale Jeannin, Barbara Bottazzi, Marina Sironi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Heparin octasaccharides inhibit angiogenesis in vivoJurjees Hasan, Steven D Shnyder, Andrew R Clamp, et al.
Human Cell|February 12, 2025
Differentiation of human hyalocytes from induced pluripotent stem cells through ascorbic acid treatmentElena Laura Mazzoldi, Gabriele Benini, Rosalba Monica Ferraro, et al.
Diabetologia|January 14, 2017
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathySara Rezzola, Michela Corsini, Paola Chiodelli, et al.
Pageof 19

Showing results (151-160 of 184) with videos related to

Sort By:
Pageof 19
The Journal of Pathology|February 21, 2013
Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancerRoberto Ronca, Patrizia Alessi, Daniela Coltrini, et al.
The Journal of Biological Chemistry|October 3, 2003
Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cellsSimona Taverna, Giulio Ghersi, Angela Ginestra, et al.
European Journal of Medicinal Chemistry|May 18, 2021
Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myelomaRiccardo Castelli, Sara Taranto, Lucia Furiassi, et al.
Angiogenesis|January 1, 1997
Endothelial cells overexpressing basic fibroblast growth factor (FGF-2) induce vascular tumors in immunodeficient miceFrancesco Sola, Anna Gualandris, Mirella Belleri, et al.
Journal of Medicinal Chemistry|February 6, 2004
Undersulfated and glycol-split heparins endowed with antiangiogenic activityBenito Casu, Marco Guerrini, Sara Guglieri, et al.
Blood|November 2, 2006
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factorHelena Stabile, Stefania Mitola, Emanuela Moroni, et al.
Immunity|May 17, 2005
Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptorsPascale Jeannin, Barbara Bottazzi, Marina Sironi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Heparin octasaccharides inhibit angiogenesis in vivoJurjees Hasan, Steven D Shnyder, Andrew R Clamp, et al.
Human Cell|February 12, 2025
Differentiation of human hyalocytes from induced pluripotent stem cells through ascorbic acid treatmentElena Laura Mazzoldi, Gabriele Benini, Rosalba Monica Ferraro, et al.
Diabetologia|January 14, 2017
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathySara Rezzola, Michela Corsini, Paola Chiodelli, et al.
Pageof 19